These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6320137)

  • 21. Effectiveness of sputum cytology using ThinPrep method for evaluation of lung cancer.
    Choi YD; Han CW; Kim JH; Oh IJ; Lee JS; Nam JH; Juhng SW; Park CS
    Diagn Cytopathol; 2008 Mar; 36(3):167-71. PubMed ID: 18232006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual cytologic manifestation of small-cell lung cancer in associated pleural effusion.
    Smith R; Nguyen GK
    Diagn Cytopathol; 2004 Apr; 30(4):266-7. PubMed ID: 15048963
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical application of the liquid-based cytological test in cytological screening of sputum for the diagnosis of lung cancer.
    Wu GP; Wang EH; Li JH; Fu ZM; Han S
    Respirology; 2009 Jan; 14(1):124-8. PubMed ID: 19144056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problem cases in lung pathology].
    Müller KM
    Pathologe; 1996 Jan; 17(1):98-101. PubMed ID: 8685105
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytological characteristics of the bronchial epithelium in lung cancer and chronic lung disease].
    Krasil'nikova LA
    Vopr Onkol; 1984; 30(4):39-43. PubMed ID: 6328758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytological studies in the diagnosis of lung cancer].
    Moskwa Z
    Wiad Lek; 1983 Feb; 36(3):219-22. PubMed ID: 6858155
    [No Abstract]   [Full Text] [Related]  

  • 27. [Three cases of double cancer: genitourinary and lung cancers].
    Mikata N; Imao S; Komatsu H
    Hinyokika Kiyo; 1993 Jan; 39(1):81-4. PubMed ID: 8384779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cellular infiltrates in lung cancer. II. Evaluation of the composition of cellular infiltrates in adenocarcinoma and small cell- and large cell carcinoma].
    Lipińska R; Szymańska D; Roszkowski W
    Pneumonol Pol; 1987 Apr; 55(4):166-71. PubMed ID: 2821515
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of the morphological structure of lung cancer on the incidence and type of regional metastases].
    Vagner RI; Blinov NN
    Vopr Onkol; 1984; 30(1):33-7. PubMed ID: 6320542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review.
    Field RW; Smith BJ; Platz CE; Robinson RA; Neuberger JS; Brus CP; Lynch CF
    J Natl Cancer Inst; 2004 Jul; 96(14):1105-7. PubMed ID: 15265973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary sarcoma of the lung].
    Sulkowski S; Kemona A; Sulik M; Dziecioł J
    Pneumonol Pol; 1989 Mar; 57(3):196-200. PubMed ID: 2626332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False-positive interpretations in respiratory cytopathology: exemplary cases and literature review.
    Policarpio-Nicolas ML; Wick MR
    Diagn Cytopathol; 2008 Jan; 36(1):13-9. PubMed ID: 18064688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic signatures for histological types of lung cancer.
    Seike M; Kondo T; Fujii K; Okano T; Yamada T; Matsuno Y; Gemma A; Kudoh S; Hirohashi S
    Proteomics; 2005 Jul; 5(11):2939-48. PubMed ID: 15996008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metachronous small cell lung carcinoma and stomach adenocarcinoma].
    Marcos Sánchez F; Viana Alonso A; Albo Castaño I; Juárez Ucelay F
    An Med Interna; 2002 Nov; 19(11):603. PubMed ID: 12522904
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study on endothelin-1 positive expression and quantitative analysis in lung cancer].
    Yang X; Liu L; Qi H
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):111-3. PubMed ID: 11263384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of occupational cancer risk in British Columbia: a population-based case-control study of 2,998 lung cancers by histopathological subtype.
    MacArthur AC; Le ND; Fang R; Band PR
    Am J Ind Med; 2009 Mar; 52(3):221-32. PubMed ID: 19058264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the primary Lung Cancer rate increase among females?
    Okutan O; Kartaloglu Z; Ilvan A; Kunter E; Cerrahoglu K; Capraz F
    Bull Cancer; 2004 Jun; 91(6):E201-10. PubMed ID: 15562564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathomorphologic and endoscopic analysis of large bronchi during lung cancer].
    Nepomniashchikh LM; Levitskiĭ VA; Nepomniashchikh GI; Aĭdagulova SV; Belov IIu; Naumova LA
    Biull Eksp Biol Med; 2000 Mar; 129(3):347-51. PubMed ID: 10776584
    [No Abstract]   [Full Text] [Related]  

  • 40. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.